RELMADA THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
RELMADA THERAPEUTICS, INC. (RLMD) reported Proceeds from Issuance of Private Placement of $22.23 million for the 6-month period ending 2014-06-30, per its 10-K filed 2015-09-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2015-09-11
- 2014-06-30: Proceeds from Issuance of Private Placement 6 month $22.23M.
- 2014-06-10: Proceeds from Issuance of Private Placement 1 month $25.75M; Proceeds from Issuance of Private Placement 1 month as first filed $25.75M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 1 month as first filed | Proceeds from Issuance of Private Placement 6 month |
|---|---|---|---|
| 2014-06-30 | $22.23M 10-K · filed 2015-09-11 | ||
| 2014-06-10 | $25.75M 10-K · filed 2015-09-11 | $25.75M 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |